Cargando…

Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression

Detalles Bibliográficos
Autores principales:	Noy, Ariela, Kaplan, Lawrence, Lee, Jeannette, Cesarman, Ethel, Tam, Wayne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330038/ http://dx.doi.org/10.1186/1750-9378-7-S1-O14

Ejemplares similares

Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
por: Chen, Meiting, et al.
Publicado: (2021)

HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era
por: Rodrigo, J. A., et al.
Publicado: (2012)

Treatment of grey zone lymphoma using the R-CODOX-M/R-IVAC protocol: Two case reports
por: Yang, Xiao-Yan, et al.
Publicado: (2017)

A Case of Double Expresser Diffuse Large B Cell Lymphoma Treated with R-CODOX-M/R-IVAC
por: Bemis, Thomas, et al.
Publicado: (2019)

Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial
por: Phillips, Elizabeth H., et al.
Publicado: (2020)

Pooled analysis of AIDS Malignancy Consortium (AMC) trials evaluating rituximab plus either CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin’s lymphoma
por: Barta, Stefan K, et al.
Publicado: (2010)

Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin’s Lymphoma (AMC-075)
por: Ramos, Juan C., et al.
Publicado: (2018)

Phase II AIDS Malignancy Consortium (AMC) trial of imatinib in AIDS-associated Kaposi’s sarcoma (KS)
por: Koon, Henry B, et al.
Publicado: (2010)

Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial()
por: McMillan, A.K., et al.
Publicado: (2020)

Simplified detection of Epstein-Barr virus for diagnosis of endemic Burkitt lymphoma
por: Gardner, Andrea, et al.
Publicado: (2022)

IRF4/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma
por: Heo, Mi Hwa, et al.
Publicado: (2017)

AMC: amyoplasia and distal arthrogryposis
por: Kimber, Eva
Publicado: (2015)

Expression IRF/MUM1>25% Predictor to Three-year Survival of Diffuse Large B Cell Lymphoma in the Immunochemotherapy Era
por: Sofo-Hafizovic, Alma, et al.
Publicado: (2016)

Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in human immunodeficiency virus-associated, B-cell non-Hodgkin lymphoma
por: Sparano, Joseph A., et al.
Publicado: (2020)

P048 Abstract Withdrawn
Publicado: (2021)

The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL
por: Lee, Sanghoon, et al.
Publicado: (2017)

PB2135: BURKITT LYMPHOMA INTERNATIONAL PROGNOSTIC INDEX (BL-IPI): IS IT EFFICIENT ENOUGH IN ADULT BURKITT LYMPHOMA PATIENTS?
por: Sayinalp, B., et al.
Publicado: (2022)

Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study
por: Haigentz, Missak, et al.
Publicado: (2022)

Case Report First-in-Man Method Description: Left Ventricular Unloading With iVAC2L During Veno-Arterial Extracorporeal Membrane Oxygenation: From Veno-Arterial Extracorporeal Membrane Oxygenation to ECMELLA to EC-iVAC®
por: Tschöpe, Carsten, et al.
Publicado: (2020)

MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B‐Cell Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
por: Ito, Masato, et al.
Publicado: (2002)

Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements
por: Frauenfeld, Leonie, et al.
Publicado: (2022)

Update on the ATCA/AMC readout cards for LHCb
por: Cachemiche, J P
Publicado: (2013)

The use of orthoses and gait analysis in children with AMC
por: Bartonek, Åsa
Publicado: (2015)

Effectiveness and Safety of a Prolonged Hemodynamic Support by the IVAC2L System in Healthy and Cardiogenic Shock Pigs
por: Delmas, Clément, et al.
Publicado: (2022)

Mum I'll sleep on grave
Publicado: (2008)

Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study
por: Strother, Robert M., et al.
Publicado: (2020)

Development of a Monitoring System for AMC13 Modules
por: Cooke, Harry George
Publicado: (2018)

aMC@NLO predictions for Wjj production at the Tevatron
por: Frederix, Rikkert, et al.
Publicado: (2011)

Describing archival materials: the use of the MARC AMC format
por: Smiraglia, Richard P
Publicado: (1990)

Web-based treatment for depression in pregnancy: a feasibility study of Mum2BMoodBooster
por: Gemmill, Alan W., et al.
Publicado: (2022)

PLP helps the mother centrosome stay mum
por: Short, Ben
Publicado: (2013)

Assessing clinical investigators’ perceptions of relevance and competency of clinical trials skills: An international AIDS Malignancy Consortium (AMC) study
por: Lee, Jeannette Y., et al.
Publicado: (2020)

Deployment of the CMS Tracker AMC as Backend for the CMS Pixel Detector
por: Auzinger, Georg
Publicado: (2015)

AMC Timing receiver and clock synthetizer module for the LLRF system
por: Czuba, K, et al.
Publicado: (2010)

Madgraph5_aMC@NLO hardware acceleration hackathon
por: Poulaillon, Jimmy
Publicado: (2023)

Software for Data Acquisition AMC Module with PCI Express Interface
por: Szachowalow, S, et al.
Publicado: (2010)

The FC7 AMC for generic DAQ & control applications in CMS
por: Pesaresi, M, et al.
Publicado: (2015)

Speeding up MadGraph5_aMC@NLO
por: Mattelaer, O., et al.
Publicado: (2021)

Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial
por: Shindiapina, Polina, et al.
Publicado: (2021)

Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab
por: Dunleavy, K, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_egnf3jogve2rdi8vka2jdae5kc